STAAR Surgical (STAA) Tops Q1 EPS by 5c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
STAAR Surgical Reports First Quarter 2026 Results; Issues Shareholder Letter
May 13, 2026 4:01 PM EDTNet Sales of $93.5 million, highest first quarter Net Sales in Companys history, up 119.6% Y/Y
Net Income of $5.2 million, with GAAP EPS of $0.10
Adjusted EBITDA1 of $24.4 million, or $0.48 per diluted share
Earnings Call and Webcast Today at 5:30 PM Eastern
LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL) for vision correction, today reported results for the first quarter... More
